← back to search

Taku Hatano

Juntendo University · JP
Area of research
Neurology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Neurological diseases and metabolism, and Advanced Neuroimaging Techniques and Applications.
h-index
45
citations
6,885
works
266
NIH funding
primary concept
Medicine
email

Recent publications

Exercise Habits in People with Parkinson's: A Multinational Survey
Movement Disorders Clinical Practice 2024cited by 2position: middledoi
Age Cutoff for Early‐Onset Parkinson's Disease: Recommendations from the International Parkinson and Movement Disorder Society Task Force on Early Onset Parkinson's Disease
Movement Disorders Clinical Practice 2022cited by 128position: middledoi
Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial
The Lancet Neurology 2021cited by 136position: middledoi
Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson’s Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD Trial
Journal of Parkinson s Disease 2021cited by 61position: middledoi
Systematic analysis of the molecular mechanisms mediated by coffee in Parkinson’s disease based on network pharmacology approach
Journal of Functional Foods 2021cited by 25position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Nobutaka Hattori · Juntendo University2 papers (2021–2021)Tanya Simuni · Northwestern University1 papers (2021–2021)Fangjun Li · Nanchang University1 papers (2021–2021)Kishore R. Kumar · The University of Sydney1 papers (2022–2022) · 1 papers (2021–2021)Kenneth Marek · Montreal Neurological Institute and Hospital1 papers (2021–2021)Pascal Minini · Sanofi (France)1 papers (2021–2021) · 1 papers (2021–2021)Jyoti Sharma · University of Alabama at Birmingham1 papers (2021–2021)Baorong Zhang · South China Agricultural University1 papers (2022–2022) · 1 papers (2021–2021)Clemens R. Scherzer · Yale University1 papers (2021–2021) · 1 papers (2021–2021)S. Pablo Sardi · Sanofi (United States)1 papers (2021–2021) · 1 papers (2022–2022)Raja Mehanna · The University of Texas Health Science Center1 papers (2022–2022)Gary Cutter · Epilepsy Foundation1 papers (2021–2021)Roy N. Alcalay · University of Alabama at Birmingham1 papers (2021–2021) · 1 papers (2022–2022)Nir Giladi · Neurim Pharmaceuticals (Israel)1 papers (2021–2021)